Financials

  • Market Capitalization 7.89 M
  • Employee 8
  • Founded 2013
  • CEO Murthy Simhambhatla
  • Website www.aeonbiopharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00Z17HDW3
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4873
ASBP
Aspire Biopharma Holdings, Inc. - Common Stock
6.02 USD+0.84%+7.69%+19.44%+285.90%7.80 M USD
4886
BOLT
Bolt Biotherapeutics, Inc. - Common Stock
3.84 USD+1.59%-4.48%-18.99%-35.46%7.38 M USD
4897
IMRN
Immuron Limited - American Depositary Shares
1.24 USD+1.64%+5.98%+6.90%-31.87%7.25 M USD
4898
ADXN
Addex Therapeutics Ltd - American Depositary Shares
5.80 USD+1.58%-8.52%-10.77%-36.61%7.15 M USD

Frequently asked questions about AEON Biopharma, Inc. Class A Common Stock

What is the AEON Biopharma, Inc. Class A Common Stock stock price today?

The current price of AEON Biopharma, Inc. Class A Common Stock (AEON) is 0.3. Over the past 24 hours, the stock has changed by -6.25%. Follow the AEON chart for real-time price dynamics.

What is the stock ticker of AEON Biopharma, Inc. Class A Common Stock?

AEON Biopharma, Inc. Class A Common Stock trades under the ticker AEON. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is AEON Biopharma, Inc. Class A Common Stock stock going up?

AEON has changed by -57.75% over the last week, -56.52% over the last month, and -71.15% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was AEON Biopharma, Inc. Class A Common Stock net income for the last quarter?

AEON Biopharma, Inc. Class A Common Stock reported net income of -11.79 M for the last quarter. The previous quarter showed -37.14 M, which means net income changed by +68.24%.

How many employees does AEON Biopharma, Inc. Class A Common Stock have?

As of the latest available data, AEON Biopharma, Inc. Class A Common Stock has 8 employees. Workforce size can provide additional context about the company's scale and operations.

What is AEON Biopharma, Inc. Class A Common Stock EBITDA?

AEON Biopharma, Inc. Class A Common Stock EBITDA is -5.99 M, and its EBITDA margin is 7 881.58%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy AEON Biopharma, Inc. Class A Common Stock stock?

You can buy AEON Biopharma, Inc. Class A Common Stock (AEON) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in AEON Biopharma, Inc. Class A Common Stock stock?

Investing in AEON Biopharma, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AEON chart and related analysis on metatrader.com as part of your research.

AEON Biopharma, Inc. Class A Common Stock

Alphaeon Corporation is a company focused on healthcare products and services based in Irvine, California. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dentistry, and dermatology.

News